CALR and melanoma: This concept is further highlighted by the observation that upon ROS-induced loss of ER proteostasis, autophagy counterbalances the mobilization of CRT on the surface of dying melanoma cells (possibly by reducing ROS-mediated loss of ER proteostasis), thereby weakening the functional interaction between dying melanoma cells with antigen-presenting cells (117).